Efficacy of Focused Extracorporeal Shock Wave Therapy After Anterior Cruciate Ligament Reconstruction
Launched by BERIVAN BERIL KILIÇ · Nov 12, 2024
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Extracorporeal shock wave therapy (ESWT) is a safe, effective and non-invasive treatment option that can be used in different pathologies of the musculoskeletal system. It is based on the production of acoustic waves that interact directly with cells through mechanotransduction and activate the metabolic process that leads to tissue remodeling. ESWT can be classified as focused ESWT (fESWT) and radial ESWT (rESWT). While rESWT has a more superficial effect and reaches the maximum energy at the skin surface and distributes it radially to the tissue, fESWT develops the maximum energy at a foc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 45 years
- • Unilateral ACL rupture
- • Isolated ACL injury
- • Hamstring graft
- Exclusion Criteria:
- • Previous knee injury and anterior cruciate ligament revision
- • Synovitis, stiffness, tension
- • History of systemic diseases such as rheumatoid arthritis, osteoarthritis, osteoporosis
- • Presence of tumor
- • Deep vein thrombosis or vascular pathology in the lower extremity
- • RA or accompanying comorbidities
- • Having had intra-articular injection within 6 months
- • Cognitive impairment
About Berivan Beril Kılıç
Berivan Beril Kılıç is a dedicated clinical trial sponsor focused on advancing medical research and innovation through rigorous clinical studies. With a commitment to enhancing patient outcomes and safety, the organization collaborates with leading healthcare professionals and institutions to conduct high-quality trials across various therapeutic areas. Leveraging a strong foundation in research ethics and regulatory compliance, Berivan Beril Kılıç aims to contribute valuable insights to the medical community while ensuring the well-being of participants throughout the trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported